Company intelligence / Profile preview

Orgenesis

Germantown, Maryland, USAcr.linkedin.com ↗

Ownership: Public · ORGS
Development stage: Commercial

Overview

Orgenesis has developed a global decentralized platform—POCare™—to enable cost-effective, scalable manufacturing of advanced cell and gene therapies at or near the point-of-care. The company partners with early-stage biotech developers to bring new CGTs into its network. Its proprietary technologies focus on reducing costs and logistical barriers associated with personalized medicine. Clinical results are not detailed in public sources; the company's main value proposition lies in enabling rapid scale-up and harmonization rather than specific late-stage clinical assets.[1][2]

Therapeutic areas: OncologyImmunologyRare DiseasesEndocrinology
Modalities: Cell therapies (CGT)Gene therapies (CGT)[1][2][3]Transdifferentiation-based therapies (e.g., for diabetes)[5]
Industry: Contract Manufacturing Organization

Drug pipeline

14 assets

ranpirnase

13 more assets in the full pipeline.

Request access →

Partnerships

Collaborates broadly with academia, research institutes, hospitals globally to commercialize point-of-care CGTs; specific major pharma partners not listed by name in available sources.[1]

Financials

Market cap: $4M
Total revenue: $347K
Enterprise value: $21.1M

Beyond the preview

Go deeper on Orgenesis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orgenesis.

Explore the full profile